July 18 (Reuters) - Amarin Corporation PLC AMRN.O :
* AMARIN IMPLEMENTS ORGANIZATIONAL RESTRUCTURING TO
STRENGTHEN THE
COMPANY WHILE DRIVING PATIENT ACCESS TO VASCEPA®/VAZKEPA®
GLOBALLY
* AMARIN CORPORATION PLC - EXPECTS RESTRUCTURING TO DRIVE
ANNUAL
COST SAVINGS OF APPROXIMATELY $40 MILLION
* AMARIN CORPORATION PLC - MAXIMIZES CASH FLOW OPPORTUNITY
THROUGH
STREAMLINED MODEL IN U.S.
* AMARIN CORPORATION PLC - IMPLEMENTING A REDUCTION IN FORCE
OF
ALL U.S. SALES FORCE POSITIONS AND APPROXIMATELY 30% OF
NON-SALES ROLES
* AMARIN CORPORATION PLC - Q2 END CASH POSITION WAS $313
MILLION
VERSUS $304 MILLION AT END OF Q1
* AMARIN CORPORATION PLC - Q2 PRODUCT REVENUE OF
APPROXIMATELY $65
MILLION
Source text for Eikon: ID:nGNE7QKvjF
Further company coverage: AMRN.O
(Reuters.Briefs@thomsonreuters.com)